Timothy A Chan

Title: The Innovative Contributions of Timothy A Chan

Introduction

Timothy A Chan is a prominent inventor based in New York, NY, known for his significant contributions to cancer research and immunotherapy. With a total of six patents to his name, Chan has made strides in understanding and treating cancer through innovative methodologies.

Latest Patents

One of Chan's latest patents focuses on "Neoantigens and uses thereof for treating cancer." This patent outlines systems and methods for determining the likely responsiveness of a human cancer subject to a checkpoint blockade immunotherapy regimen. The process involves obtaining sequencing reads from cancer samples, determining human leukocyte antigen types, and computing clone fitness scores based on neoantigens. Another notable patent describes "Determinants of cancer response to immunotherapy," which details molecular determinants and tools for identifying cancers likely to respond to such treatments.

Career Highlights

Chan has worked at the prestigious Memorial Sloan Kettering Cancer Center, where he has contributed to groundbreaking research in cancer treatment. His work has been instrumental in advancing the field of immunotherapy, providing new insights into how cancers can be effectively targeted and treated.

Collaborations

Throughout his career, Chan has collaborated with notable colleagues, including Marta Luksza and Vinod P Balachandran. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in cancer therapies.

Conclusion

Timothy A Chan's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patents and research contributions continue to pave the way for advancements in immunotherapy, showcasing the vital role of inventors in the medical field.